1. Myeloid-derived suppressor cells can be efficiently generated from human hematopoietic progenitors and peripheral blood monocytes
   Sílvia Casacuberta-Serra et al, 2017, Immunol Cell Biol CrossRef
2. Differentiation of Murine Myeloid-Derived Suppressor Cells
   David Escors, 2016 CrossRef
3. Circulating and tumor-infiltrating arginase 1-expressing cells in gastric adenocarcinoma patients were mainly immature and monocytic Myeloid-derived suppressor cells
   WeiHong Ren et al, 2020, Sci Rep CrossRef
4. Serum CXCL13 and PECAM-1 can be used as diagnostic and prognostic markers in elderly patients with gastric cancer
   Y. Li et al, 2020, Clin Transl Oncol CrossRef
5. Mechanisms of immune suppression by myeloid-derived suppressor cells: the role of interleukin-10 as a key immunoregulatory cytokine
   Mahmoud Mohammad Yaseen et al, 2020, Open Biol. CrossRef
6. Myeloid-Derived Suppressor Cells: A Multifaceted Accomplice in Tumor Progression
   Jia-Nan Cheng et al, 2021, Front. Cell Dev. Biol. CrossRef
7. Tissue-Resident Innate Immune Cell-Based Therapy: A Cornerstone of Immunotherapy Strategies for Cancer Treatment
   Rosalia Busà et al, 2022, Front. Cell Dev. Biol. CrossRef
8. The Role of CXC Chemokines in Cancer Progression
   Tiantian Wu et al, 2022, Cancers CrossRef
9. Viral nanoparticle vaccines against S100A9 reduce lung tumor seeding and metastasis
   Young Hun Chung et al, 2023, Proc. Natl. Acad. Sci. U.S.A. CrossRef
10. Novel therapeutic strategies targeting myeloid-derived suppressor cell immunosuppressive mechanisms for cancer treatment
    Eric Jou et al, 2024 CrossRef